Miho Narimasa, Ishida Takafumi, Kuwaba Noriko, Ishida Mari, Shimote-Abe Keiko, Tabuchi Kumiko, Oshima Tetsuya, Yoshizumi Masao, Chayama Kazuaki
Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Japan.
Cardiovasc Res. 2005 Nov 1;68(2):289-98. doi: 10.1016/j.cardiores.2005.05.029. Epub 2005 Jun 23.
Thrombin induces leukocyte adherence to endothelial cells via increased expression of intercellular adhesion molecule-1 (ICAM-1). Although ICAM-1 expression is regulated by NF-kappaB, recent studies have suggested that additional signaling mechanisms may also be involved. The goal of this study was to determine whether mitogen-activated protein (MAP) kinases, including extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 MAP kinase (p38), mediate thrombin-induced ICAM-1 expression in endothelial cells.
Western blot analysis using anti-ICAM-1 antibody and luciferase assays were performed in cultured endothelial cells after addition of signal transduction inhibitors or transfection of various gene constructs. JNK kinase activity was determined by a kinase assay using c-Jun as a substrate or by Western blot analysis with anti-phospho-JNK antibody.
Treatment of endothelial cells with the JNK-specific inhibitors, SP600125 or JNK inhibitory peptide 1 (JNKI1), resulted in a significant decrease in thrombin-induced ICAM-1 expression as demonstrated by Western blot analysis (67 +/- 3% and 72 +/- 7%, respectively). In contrast, inhibitors of MEK and p38 had only minimal effect. The combination of SP600125 and the NF-kappaB inhibitor, BAY11-7082, resulted in complete inhibition of thrombin-induced ICAM-1 expression. The Galpha(q) inhibitor, YM-254890, inhibited thrombin-induced JNK activation and ICAM-1 expression. Dominant-negative Ras and Rac1, but not Rho, inhibited thrombin-induced JNK activation and ICAM-1 promoter activity. Finally, thrombin-induced JNK activation and ICAM-1 promoter activity were inhibited by betaARK1ct (a Gbetagamma subunit scavenger) and Csk.
These data suggest that, in concert with NF-kappaB, JNK regulates thrombin-induced ICAM-1 expression by a mechanism that is dependent on Galpha(q), Gbetagamma, Ras, Rac1 and the Src kinase family.
凝血酶通过增加细胞间黏附分子-1(ICAM-1)的表达诱导白细胞黏附于内皮细胞。尽管ICAM-1的表达受核因子κB(NF-κB)调控,但最近的研究表明可能还涉及其他信号传导机制。本研究的目的是确定丝裂原活化蛋白(MAP)激酶,包括细胞外信号调节激酶1/2(ERK1/2)、c-Jun氨基末端激酶(JNK)和p38 MAP激酶(p38)是否介导凝血酶诱导的内皮细胞ICAM-1表达。
在添加信号转导抑制剂或转染各种基因构建体后,对培养的内皮细胞进行使用抗ICAM-1抗体的蛋白质印迹分析和荧光素酶测定。通过以c-Jun为底物的激酶测定或使用抗磷酸化JNK抗体的蛋白质印迹分析来确定JNK激酶活性。
用JNK特异性抑制剂SP600125或JNK抑制肽1(JNKI1)处理内皮细胞,蛋白质印迹分析显示凝血酶诱导的ICAM-1表达显著降低(分别为67±3%和72±7%)。相比之下,MEK和p38的抑制剂作用甚微。SP600125与NF-κB抑制剂BAY11-7082联合使用可完全抑制凝血酶诱导的ICAM-1表达。Gαq抑制剂YM-254890可抑制凝血酶诱导的JNK活化和ICAM-1表达。显性负性Ras和Rac1而非Rho可抑制凝血酶诱导的JNK活化和ICAM-1启动子活性。最后,βARK1ct(一种Gβγ亚基清除剂)和Csk可抑制凝血酶诱导的JNK活化和ICAM-1启动子活性。
这些数据表明,JNK与NF-κB协同作用,通过一种依赖于Gαq、Gβγ、Ras、Rac1和Src激酶家族的机制调节凝血酶诱导的ICAM-1表达。